October 27th (9:00 a.m. MDT)

Title: Technical Development, Optimization, and Clinical Implementation of Quantitative Magnetic Resonance Imaging Methods for Radiation Oncology

Summary: Magnetic resonance imaging (MRI) has gradually grown more important in the field of radiation oncology. This paradigm shift has grown from initial experiments with MRI of cancerous lesions in the early 1970s, to the integration of MRI images for radiation therapy treatment planning (i.e., MRI-Simulation) in the early 1980s, to the combined MRI linear accelerator (MR-Linac) becoming commercially available in 2018 which can simultaneously image a tumor and treat it with radiation. However, due to its novelty in radiation oncology, its full potential for the integration of quantitative MRI-based biomarkers has yet to be fully realized. Therefore, this talk will provide a framework for this integration from the initial technical developments, to the subsequent optimization, to the ultimate clinical implementation in the radiation oncology workflow. This work will be presented in three distinct aims: 1) the technical development of quantitative MRI techniques in radiation oncology, 2) the technical optimization of these techniques for site-specific applications, and 3) their clinical implementation and potential use cases. Several techniques will be explored for quantitative T1, T2, PD, R2*, proton density fat fraction (PDFF), and triglyceride composition mapping. Most of the techniques presented will acquire multiple of these quantitative parameters simultaneously due to the unique time constraints in radiation oncology, especially on the integrated MR-Linac.

Speaker Bio: Lucas McCullum completed his B.S. in Mechanical Engineering and B.A. in Applied Mathematics at The University of Maryland – Baltimore County in 2019. Following this, he worked as a research software engineer at the Massachusetts Institute of Technology in the Laboratory for Computational Physiology under the advisership of Dr. Roger Mark M.D., Ph.D. developing open-source tools and databases for health informatics. He then worked as a research assistant at Massachusetts General Hospital in the laboratory of Dr. Harald Paganetti Ph.D. and Dr. Clemens Grassberger Ph.D. focusing on computational simulations of lymphocyte depletion during radiation therapy. In 2022, he started his Ph.D. in Medical Physics at The University of Texas MD Anderson Cancer Center Graduate School of Biomedical Sciences under the advisership of Dr. Clifton D. Fuller M.D., Ph.D. where he developed and clinically implemented quantitative magnetic resonance imaging techniques in the radiation oncology department and successfully defended his Ph.D. in 2026. He is currently a medical physics resident in diagnostic imaging and nuclear medicine at Boston Children’s Hospital and Harvard Medical School.

Format: One hour call – Presentation followed by Q&A

For registration, please reach out to CaliberMRI.

Related Articles

CaliberMRI announces release of the qDisc, a new quantitative MRI phantom for added functionality of the Medium ACR Phantom

BOULDER, Colo., Nov. 26, 2025 /PRNewswire/ — CaliberMRI, an industry leader in standardizing Magnetic Resonance Imaging (MRI), announced the release of a new quantitative MRI phantom compatible with the Medium ACR phantom. CaliberMRI’s qDisc (quantitative Dual Imaging Standardization Compartment) Model 141 allows sites to baseline T1, T2, ADC, and Proton Density in a single slice when scanning the Medium ACR phantom. The qDisc includes the Company’s patented MR readable LC Thermometer and is supported by qCal-MR®, an automated QA/QC analysis software. “This offering provides a practical option for gathering important quantitative metrics during routine scans with an ACR phantom,” says William Hollander, CEO of CaliberMRI. “With the rise of quantitative MRI offerings, the qDisc can be used as a first step toward harmonization of MRI scanners and AI software for analysis”. Hollander added. This phantom is intended to complement CaliberMRI’s more complete phantom platform solutions.

APS Session – Multiparametric Tissue Mimics for Breast Imaging and Medical Device Testing

Multiparametric Tissue Mimics for Breast Imaging and Medical Device Testing
Stephen Russek, Todor Karaulanov (presenter), Willaim Hollander, Chamni Jayarathna, Callie Weiant, John Wenzel, Shannon John

We present our work on developing anatomically realistic, quantitative multiparametric MRI (qMRI) phantoms designed to standardize imaging of both healthy and diseased breast tissue. The lack of standardized, morphology-accurate phantoms currently limits the effectiveness of qMRI in both clinical and research settings. Without realistic tissue-mimicking models, radiologists, technologists, and researchers face challenges in learning optimal acquisition protocols and interpreting quantitative data.

CaliberMRI User Group Session 2 – June – The variability of Mean ADC Measurements with Simultaneous Multi-slice Imaging in a NIST/QIBA/CaliberMRI Diffusion Phantom

Join us for Session 2:  Tuesday, June 24th, 9:00 AM (MDT).  To sign up or for login details, please email info[at]qmri.com.
Topic: The variability of Mean ADC Measurements with Simultaneous Multi-slice Imaging in a NIST/QIBA/CaliberMRI Diffusion Phantom
Guest Speakers: Dr. Ryckie Wade, PhD, and Matthew Marzetti, MsC, University of Leeds, United Kingdom

Join us at ISMRM – Booth C15

Advancing Quantitative MRI! Stop by to visit our Booth (C19) at ISMRM to talk about data quality, standardization, reproducibility, and quantitative imaging in the age of AI. Topics: clinical trials, QA/QC, R&D, and AI/ML validation/testing.

Open Office Hours – Every Tuesday 9-10 a.m. MDT!

Join us for open office hours! Ask questions about your phantom, qCal-MR and meet others advancing quantitative MRI!

Important Meeting Alert – Please Join the Conversation NIST/NIBIB Symposium on Medical Metrology and Standards for American Healthcare and Commerce Medical Imaging, Devices, Diagnostics 

Important Meeting Alert – Please Join the ConversationNIST/NIBIB Symposium on Medical Metrology and Standards for American Healthcare and Commerce Medical Imaging, Devices, Diagnostics The Question: What future medical measurements, metrology, and standards should be prioritized to support U.S. Healthcare?

Article Word Cloud!

Take a look at our word cloud: qMRI, imaging, diffusion, T1, T2 ADC Mapping! Reproduciblity! QA/QC! Repeatability, Reproducibility, QA/QC!

Great Reading For ASTRO!

Are you heading to ASTRO next week?  If so, take a look at some incredible articles below (some hot off the press!).  Please reach out directly to authors on their work or to CaliberMRI on our phantoms.  If you’d like to set up a meeting at ASTRO, please reach out to us directly at info@qmri.com. […]

2025 User Group Session Calendar!

We are excited to share our 2025 User Group Sessions!  Mark your calendars: SESSION 1: Tuesday, April 1st, 9:00 a.m. MDT Topic: Annual Physics Testing with the CaliberMRI Mini Hybrid Phantom. Guest Speaker: Norman P. Sipp, MS DABR, Chief Diagnostic Medical Physicist: Ascension Seton Network-Austin, TX SESSION 2: Tuesday, June 24th, 9:00 a.m. MDT Topic: […]

April User Group Session! Multisite MRI Intravoxel Incoherent Motion Repeatability and Reproducibility across 3 T Scanners in a Breast Diffusion Phantom: A BReast Intravoxel Incoherent Motion Multisite (BRIMM) Study

Multisite MRI Intravoxel Incoherent Motion Repeatability and Reproducibility across 3 T Scanners in a Breast Diffusion Phantom: A BReast Intravoxel Incoherent Motion Multisite (BRIMM) Study

November 18th – User Group Session | Traumatic Brain Injury, the TRACK-TBI Study, Data, and Quantitative Imaging | Dr. Pratik Mukherjee (UCSF)

Topic: Traumatic Brain Injury, the TRACK-TBI Study, Data, and Quantitative Imaging
Guest Speaker:  Dr. Pratik Mukherjee MD, PhD, UCSF

Dr. Mukherjee is a Professor in Residence in the Department Radiology and Biomedical Imaging, Bioengineering, and he is an attending neuroradiologist at the University of California, San Francisco. He is the Director of the Center for Imaging of Neurodegenerative Disease (CIND) based at the San Francisco VA Medical Center. He also directs the Neural Connectivity Laboratory (NCL) at UCSF China Basin.

 Dr. Mukherjee’s primary clinical research is the study of neurodevelopmental disorders and traumatic brain injury (TBI) using advanced neuroimaging and artificial intelligence/machine learning (AI/ML) technology. His research has been focused on technical development, neuroscience and clinical applications of advanced imaging methods for mapping structure and function of the human brain, especially diffusion MRI, which is a popular technique for assessing the development and integrity of white matter and for mapping axonal fiber pathways.
 Scope:  Dr. Mukherjee will discuss his work on traumatic brain injury with the TRACK-TBI trial and on advanced neuroimaging and artificial intelligence/machine learning (AI/ML) technology.

Upcoming User Group Sessions – Join Us!

Please join us for our upcoming user group sessions! We’ll be discussing MR-Linac, Diffusion, Repeatability, and Relaxometry.